Study of OXB-102 (AXO-Lenti-PD) in Patients With Bilateral, Idiopathic Parkinson's Disease

计划入组 6 人 · 首次发布于 2018 年 10 月 25 日

To Study the Peripheral Effect of Botulinum Toxin-A (Botox-A) on Experimentally Induced Cutaneous Pain in Healthy Subjects

首次发布于 2007 年 2 月 15 日

Healthetech, Inc. SMART Study

计划入组 56 人 · 首次发布于 2005 年 9 月 19 日

US-APR2020

OXB-202

OXB-204

US Biotest, Inc.

United States

Morphosys US Inc.

United States

Moderna US, Inc.

United States

Oxford BioMedica Achieves Full Ownership of US Subsidiary to Strengthen Global Gene Therapy Manufacturing Network

OXB Selected as GMP Manufacturing Partner for Plowshare Therapies' AAV Gene Therapy Programme Targeting Rare Genetic Diseases

Biofrontera Inc. Completes $11M Asset Acquisition of Ameluz and RhodoLED US Rights